Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Dominguez Pazos (A Coruña, Spain), M. Blanco Aparicio (A Coruña, Spain), B. Fernández Pérez (A Coruña, Spain), M. González Bardanca (A Coruña, Spain), M. Fernández Marrube (A Coruña, Spain), E. Elguezabal Bilbao (A Coruña, Spain), F. Méndez Salazar (A Coruña, Spain), G. Bou Arévalo (A Coruña, Spain), C. Montero Martínez (A Coruña, Spain). Profitability of sputum culture of samples classified as "not valid" by the criteria of Murray and Washington in patients with non-cystic fibrosis bronchiectasis.. 2169

Member's Comments

No comment yet.

Related content which might interest you: Exacerbations in non- cystic fibrosis bronchiectasis (NCFB): is there a difference between self-reported events and those defined by the criteria in the literature? Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Inflammatuary markers in induced sputum and clinical parameters in children with non-cystic fibrosis bronchiectasis Source: Annual Congress 2004 - Chronic respiratory illness in childhood Year: 2004 Patients hospitalised with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Microbiological yield of oropharyngeal swab compared to induced sputum in children with cystic fibrosis (CF) < 5 years of age Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Is induced sputum more useful than expectorated sputum to identify respiratory pathogens in children with cystic fibrosis? Source: Eur Respir J 2007; 30: Suppl. 51, 31s Year: 2007 Clinical and functional profile of patients with non-cystic fibrosis bronchiectasis according to the presence of chronic bronchial infection Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Diagnostic value of the Biofire® Filmarray Pneumonia panel compared to conventional sputum culture in patients with an exacerbation of bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Sputum characteristics of stable COPD patients after a first admission for an exacerbation. The "phenotype and course of COPD" (PAC-COPD) study Source: Eur Respir J 2006; 28: Suppl. 50, 549s Year: 2006 Microbiology of induced sputum vs oropharyngeal culture in cystic fibrosis patients not producers of spontaneous sputum Source: Eur Respir J 2007; 30: Suppl. 51, 647s Year: 2007 Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis Source: Eur Respir J 2009; 33: 361-364 Year: 2009 The effect of gender on sputum microbiological profile in non-cystic fibrosis bronchiectasis Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Sputum inflammatory cells in COPD patients classified according to GOLD 2011 guidelines Source: Eur Respir J 2016; 47: 978-980 Year: 2016 Microbial findings in children with cystic fibrosis. The value of bronchoscopy Source: Annual Congress 2005 - Paediatric bronchology - a broad field Year: 2005 Sputum bacterial concentrations and exacerbations of non cystic fibrosis bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Endotyping of COPD, bronchiectasis and their overlap syndrome by integrated sputum proteome/microbiome Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2019 To identify cases of invasive pulmonary aspergillosis in patients of COPD with sputum positive for aspergillus by applying existing criteria Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Accompanying asthma in cystic fibrosis (CF) and non-CF bronchiectatic patients: could we detect it with AMP bronchoprovocation and sputum properties? Source: Eur Respir J 2007; 30: Suppl. 51, 374s Year: 2007 Leicester cough questionnaire and sputum colour chart assessment in non-cystic fibrosis bronchiectasis: A cohort analysis Source: Annual Congress 2011 - Clinical parameters in airway diseases Year: 2011 Fungi communities detected by metagenomic tools in sputum in patients with cystic fibrosis Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013